General Surgery

Featured Areas

Faculty

D. Albertson, MD

M. Chang, MD

M. Edwards, MD

A. Farney, MD

A. Fernandez, MD

R. Geary, MD

K. Hansen, MD

A. Hildreth, MD

J. Holmes, MD

J. Hoth, MD

M. Howard-McNatt

R. Howerton, MD

E. Levine, MD

S. McNatt, MD

P. Miller, MD

N. Mowery, MD

J. Petty, MD

G. Plonk, MD.

T. Pranikoff, MD

J. Rogers, MD

P. Shen, MD

J. Stewart, MD

R. Stratta, MD

Ch. Turner, MD

G. Waters, MD

C. Westcott, MD

Residency Program

Surgical Sciences

Patient Care

Contact Us

Surgery Atlas

WFUBMC Home

>

General Surgery

>

Faculty

>

P. Shen, MD

Perry Shen, MD., FACS. Associate Professor of Surgery Section on Surgical Oncology Publications   Dr. Perry Shen is 1 of 4 clinical faculty members of the Surgical Oncology Service. He completed his undergraduate training at the University of California, Irvine in 1988, and received his medical degree at the University of Southern California in 1992. His internship was performed at the Johns Hopkins Hospital (1992-1993) and his general surgical residency was obtained at the University of Southern California  Los Angeles County Medical Center (1993-1998). He completed a surgical oncology fellowship at the John Wayne Cancer Institute from 1998-2000. After his surgical training, Dr. Shen joined the faculty at Wake Forest University in August 2000. Dr. Shen's clinical interests are related to general surgical oncology with a focus on hepatopancreatobiliary malignancies. He has expertise in the areas of melanoma, sarcoma, liver and pancreas tumors, and gastrointestinal cancers. He is director of the Hepatobiliary Oncology Multidisciplinary Conference at the Outpatient Comprehensive Cancer Center. Dr. Shen is the principal investigator for several protocols studying novel therapeutic modalities for primary and metastatic hepatic tumors and pancreas cancer. These involve immunotherapy for pancreas cancer and isolated hepatic perfusion for unresectable liver cancer. He is also part of the Wake Forest University program of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis, which is the second largest program in the country. He is Chair of the American College of Surgeons Committee on Young Surgeons Group and also the Chair of the GI Surgery Subcommittee for the Cancer and Leukemia Group B Cancer Cooperative. He is also the recipient of several intramural grants funding translational research involving the genomic analysis of metastatic colon cancer in collaboration with the cancer biology department.   Referrals Benefits Winston - Salem   Last Updated: March 5, 2009